<?xml version="1.0"?>
<Articles JournalTitle="The Research in Heart Yield and Translational Medicine (RHYTHM)">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>03</Month>
        <Day>14</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">In-Hospital Outcome of Patients with Diabetes Mellitus after CTO Recanalization with Third-Generation Drug-Eluting Stents</title>
    <FirstPage>47</FirstPage>
    <LastPage>52</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Jan</FirstName>
        <LastName>Guelker</LastName>
        <affiliation locale="en_US">Department of Cardiology, Heart Centre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany.  AND  Institute for Heart and Circulation Research, University Cologne, Cologne, Germany.</affiliation>
      </Author>
      <Author>
        <FirstName>Lars</FirstName>
        <LastName>Bansemir</LastName>
        <affiliation locale="en_US">Department of Cardiology, Heart Centre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany.  AND  Institute for Heart and Circulation Research, University Cologne, Cologne, Germany.</affiliation>
      </Author>
      <Author>
        <FirstName>Rainer</FirstName>
        <LastName>Ott</LastName>
        <affiliation locale="en_US">Department of Cardiology, Heart Centre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany.  AND  Institute for Heart and Circulation Research, University Cologne, Cologne, Germany.</affiliation>
      </Author>
      <Author>
        <FirstName>Thomas</FirstName>
        <LastName>Rock</LastName>
        <affiliation locale="en_US">Department of Cardiology, Heart Centre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany.  AND  Institute for Heart and Circulation Research, University Cologne, Cologne, Germany.</affiliation>
      </Author>
      <Author>
        <FirstName>Rosemarie</FirstName>
        <LastName>Guelker</LastName>
        <affiliation locale="en_US">RWI-Leibniz-Institute for Economic Research, Essen, Germany.</affiliation>
      </Author>
      <Author>
        <FirstName>Dong-In</FirstName>
        <LastName>Shin</LastName>
        <affiliation locale="en_US">Department of Cardiology, Heart Centre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany.  AND  Institute for Heart and Circulation Research, University Cologne, Cologne, Germany.</affiliation>
      </Author>
      <Author>
        <FirstName>Heinrich</FirstName>
        <LastName>Klues</LastName>
        <affiliation locale="en_US">Department of Cardiology, Heart Centre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany.  AND  Institute for Heart and Circulation Research, University Cologne, Cologne, Germany.</affiliation>
      </Author>
      <Author>
        <FirstName>Alexander</FirstName>
        <LastName>Bufe</LastName>
        <affiliation locale="en_US">Department of Cardiology, Heart Centre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany.  AND  Institute for Heart and Circulation Research, University Cologne, Cologne, Germany. AND Witten/Herdecke University, Witten, Germany.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>12</Month>
        <Day>14</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>10</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Percutaneous coronary intervention (PCI) of total chronic coronary occlusions (CTOs) still remains a major challenge in interventional cardiology. There is little knowledge in the literature about differences in CTO-PCI between diabetic and nondiabetic patients in the era of third-generation drug-eluting stents (DESs). In this study, we analyzed the impact of diabetes mellitus (DM) on procedural characteristics, complications, and acute outcomes in a cohort of 440 patients.
Methods: Between 2012 and 2016, we recruited 440 consecutive patients, 116 of them with DM. All the patients underwent PCI for at least 1 CTO. Antegrade and retrograde CTO recanalization techniques were applied. Only third-generation DESs were used. We used t-tests and the Pearson chi-quadrat test to test the significant differences in the variables between the 2 groups.
Results: The patients with DM were older than the nondiabetics (64.5 y vs. 61.1 y; P=0.003), and they suffered more frequently from a chronic kidney disease (7.1% vs. 2.4%; P=0.001). The nondiabetics less frequently had arterial hypertension (75.3% vs. 89.7%; P=0.001); however, they more often had a family liability for CAD (32.1% vs. 22.4%; P=0.050) and had a higher left ventricular&#xA0; ejection fraction (59.2% vs. 56.7%; P=0.011). The success rate was 85.2% in the patients without DM and 81.2% in the patients with DM (P=0.403). The existence of DM had no impact on the procedural success and complication rates.
Conclusion: Our study on 440 patients shows that diabetics and nondiabetics have similar success and complication rates after the recanalization of CTOs using third-generation DESs. It is a feasible and safe procedure and can be recommended as an alternative treatment.</abstract>
    <web_url>https://rhythm.tums.ac.ir/index.php/jthc/article/view/637</web_url>
    <pdf_url>https://rhythm.tums.ac.ir/index.php/jthc/article/download/637/831</pdf_url>
  </Article>
</Articles>
